Your browser doesn't support javascript.
loading
Preservation of quality of life in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial).
Mueller, Volkmar; Wardley, Andrew; Paplomata, Elisavet; Hamilton, Erika; Zelnak, Amelia; Fehrenbacher, Louis; Jakobsen, Erik; Curtit, Elsa; Boyle, Frances; Harder Brix, Eva; Brenner, Andrew; Crouzet, Laurence; Ferrario, Cristiano; Muñoz-Mateu, Montserrat; Arkenau, Hendrik-Tobias; Iqbal, Nayyer; Aithal, Sramila; Block, Margaret; Cold, Soeren; Cancel, Mathilde; Hahn, Olwen; Poosarla, Teja; Stringer-Reasor, Erica; Colleoni, Marco; Cameron, David; Curigliano, Giuseppe; Siadak, Muriel; DeBusk, Kendra; Ramos, Jorge; Feng, Wentao; Gelmon, Karen.
Afiliación
  • Mueller V; Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: v.mueller@uke.de.
  • Wardley A; Manchester Breast Centre, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology Medicine & Health, University of Manchester, Manchester, UK.
  • Paplomata E; Carbone Comprehensive Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.
  • Hamilton E; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA.
  • Zelnak A; Northside Hospital, Sandy Springs, GA, USA.
  • Fehrenbacher L; Kaiser Foundation Research Institute, Oakland, CA, USA.
  • Jakobsen E; Sygehus Lillebaelt - Vejle Sygehus, Denmark.
  • Curtit E; University Hospital of Besançon, Besançon, France.
  • Boyle F; Mater Hospital North Sydney, NSW, Australia.
  • Harder Brix E; Herlev Hospital, Herlev, Denmark.
  • Brenner A; Mays Cancer Center at the UT Health San Antonio, San Antonio, TX, USA.
  • Crouzet L; Center Eugene Marquis, Rennes, France.
  • Ferrario C; Jewish General Hospital, Montreal, Quebec, Canada.
  • Muñoz-Mateu M; Hospital Clinic de Barcelona, Translational Genomics and Targeted Therapeutics, Institut d'Investigacions Biomèdiques Pi i Sunyer-IDIBAPS, Barcelona, Spain.
  • Arkenau HT; Sarah Cannon Research Institute UK and Cancer Institute, University College London, London, UK.
  • Iqbal N; Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada.
  • Aithal S; Cancer Treatment Centers of America / Eastern Regional Medical Center, Philadelphia, PA, USA.
  • Block M; Nebraska Cancer Specialists, Omaha, NE, USA.
  • Cold S; Odense University Hospital, Odense, Denmark.
  • Cancel M; CHU Tours - Hopital Bretonneau, Tours, France.
  • Hahn O; University of Chicago Medical Center, Chicago, IL, USA.
  • Poosarla T; Mitchell Cancer Institute, University of South Alabama, Mobile, AL, USA.
  • Stringer-Reasor E; Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Colleoni M; IEO, European Institute of Oncology, IRCCS, Milan, Italy.
  • Cameron D; Edinburgh Cancer Research Centre, IGMM, University of Edinburgh, Edinburgh, Scotland.
  • Curigliano G; European Institute of Oncology, IRCCS, and University of Milano, Milan, Italy.
  • Siadak M; Medical Affairs, Seagen, Inc, Bothell, WA, USA.
  • DeBusk K; Health Economics Outcome Research, Seagen Inc., Bothell, WA, USA.
  • Ramos J; Clinical Development, Seagen Inc., Bothell, WA, USA.
  • Feng W; Biometrics, Seagen Inc., Bothell, WA, USA.
  • Gelmon K; British Columbia Cancer Agency - Vancouver Centre, Vancouver, BC, Canada.
Eur J Cancer ; 153: 223-233, 2021 08.
Article en En | MEDLINE | ID: mdl-34214937
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oxazoles / Piridinas / Quinazolinas / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Capecitabina / Trastuzumab Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oxazoles / Piridinas / Quinazolinas / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 / Capecitabina / Trastuzumab Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Año: 2021 Tipo del documento: Article